tweetindex

AbbVie

@abbvie · Global · joined 21 Mar 2012

Official global handle sharing the latest news about our company, science & people. Review our guidelines: https://t.co/pvWvxd2VWF

79 299Followers
462Following
8 801Posts total
7.8KViews on collected posts

Against accounts of the same size

8 posts from the last 90 days, next to the 10K–100K follower range. below its peers on both reach and engagement.

Median views917this account2 578median for 10K–100K
Reach, %1.16%this account7.77%median for 10K–100K
Engagement, %0.32%this account1.47%median for 10K–100K
MetricThis accountMedian for 10K–100KRatio
Median views per post9172 5780.36×
Reach (views ÷ followers)1.16%7.77%0.15×
Engagement rate0.32%1.47%0.21×

Others in this range →   Compare with another account →   How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.4K21 Aug
541
2824 Aug
1.7K27 Aug
1129 Aug
1.5K3 Sep
1.3K
3404 Sep

Last 8 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.42%21 Aug
0.37%
0.00%24 Aug
0.41%27 Aug
0.00%29 Aug
0.26%3 Sep
0.46%
0.00%4 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.47%.

What the audience does

Likes58.6%17 in total
Reposts10.3%3 in total
Replies24.1%7 in total
Quotes6.9%2 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

Personalized care starts when a patient’s voice is heard. For Johannes, this means open dialogue with his care team to align choices with his priorities. This #WorldLeukemiaDay, we advocate for reciprocal communication that empowers patients to take an active role in their care. 340 views · 0 likes · 0 reposts · 0 replies 04 Sep 2026 New topline results are available from our Phase 3 study in patients with relapsed/refractory #MultipleMyeloma (RRMM), and we look forward to sharing the full data at this year’s @Myeloma_Society Annual Meeting. Read more: https://t.co/Qx1rjb26cS #IMS26 https://t.co/vZsf2ycn9n 1.3K views · 1 likes · 1 reposts · 3 replies 03 Sep 2026 Apogee Therapeutics is now part of AbbVie. This builds on our decades of #immunology leadership and adds to our diverse pipeline focused on elevating the standard of care for patients. Learn more: https://t.co/HTGUgyXkrX $ABBV https://t.co/0ZNmFUIV0G 1.5K views · 3 likes · 0 reposts · 1 replies 03 Sep 2026 @abbvie @EMA_News Help me. I need ur medicine 11 views · 0 likes · 0 reposts · 0 replies 29 Aug 2026 JUST IN: Learn about our submission to the @EMA_News for subcutaneous induction of one of our medicines in adults with moderately to severely active #CrohnsDisease: https://t.co/n22gi2cLPB https://t.co/CmbncEnHvH 1.7K views · 6 likes · 0 reposts · 1 replies 27 Aug 2026 @abbvie @IASLC I started taking Skyrizi...took my 2nd loading dose about mid May, my skin is clear and the psoriatic arthritis in my hands has improved... joint pain relief took a bit longer to achieve but my hands feel a lot better, thanks AbbVie 👍 28 views · 0 likes · 0 reposts · 0 replies 24 Aug 2026 [Video description: On-screen text reads, "Oncology News"] 541 views · 1 likes · 1 reposts · 0 replies 21 Aug 2026 At this year's @IASLC's World Conference on Lung Cancer, we're sharing new data across lung cancer, including #NSCLC and #SCLC. Read more: https://t.co/gfcIYgB0cd #WCLC26 https://t.co/OVtAF9AU8f 2.4K views · 6 likes · 1 reposts · 2 replies 21 Aug 2026

Similar accounts